Topics
.jpg%3Fwidth%3D300&w=3840&q=75)
antiretroviralDrug
Some two agents antiretroviral regimens have demonstrated comparable efficacy to three agents regimens for maintenance therapy. The aim of this retrospective study is evaluate efficacy and safety of two agents regimens (3TC+DTG or 3TC+boosted PI) after 48 weeks of switching from standard three agents regimens. The switch to two agents regimens was proposed for simplification or toxicity due to the previous treatment
A regimen with rilpivirine (RPV), abacavir (ABC) and lamivudine (3TC) is simple and may allow the sp...
To compare the efficacy and safety of an individualized treatment-simplification strategy consisting...
To compare the efficacy and safety of an individualized treatment-simplification strategy consisting...
Background: Aim of the study was to assess predictors of discontinuation/toxicity of boosted PI-base...
Background: Aim of the study was to assess predictors of discontinuation/toxicity of boosted PI-base...
Background Some guidelines recommended two-drug antiretroviral therapies as alternative regimens to ...
Since 1996, the standard of care (SOC) therapy for HIV treatment has consisted of a backbone of two ...
The use of a combination antiretroviral therapy (cART) has changed dramatically the prognosis and th...
BackgroundSince 1996, the standard of care (SOC) therapy for HIV treatment has consisted of a backbo...
Background: Aim of the study was to assess predictors of discontinuation/toxicity of boosted PI-base...
Aim Combined antiretroviral treatment (cART) traditionally consists of three antiretroviral medicati...
Background: To assess the role of drugs used in dual therapy (DT), as cART simplification, over the ...
The unparalleled success of combination antiretroviral therapy (cART) is based on the combination of...
Evaluation of the switch to a dual ART regimen with lamivudine plus dolutegravir or protease inhibit...
As people live longer with HIV infection, there has been a resurgence of interest in challenging the...
A regimen with rilpivirine (RPV), abacavir (ABC) and lamivudine (3TC) is simple and may allow the sp...
To compare the efficacy and safety of an individualized treatment-simplification strategy consisting...
To compare the efficacy and safety of an individualized treatment-simplification strategy consisting...
Background: Aim of the study was to assess predictors of discontinuation/toxicity of boosted PI-base...
Background: Aim of the study was to assess predictors of discontinuation/toxicity of boosted PI-base...
Background Some guidelines recommended two-drug antiretroviral therapies as alternative regimens to ...
Since 1996, the standard of care (SOC) therapy for HIV treatment has consisted of a backbone of two ...
The use of a combination antiretroviral therapy (cART) has changed dramatically the prognosis and th...
BackgroundSince 1996, the standard of care (SOC) therapy for HIV treatment has consisted of a backbo...
Background: Aim of the study was to assess predictors of discontinuation/toxicity of boosted PI-base...
Aim Combined antiretroviral treatment (cART) traditionally consists of three antiretroviral medicati...
Background: To assess the role of drugs used in dual therapy (DT), as cART simplification, over the ...
The unparalleled success of combination antiretroviral therapy (cART) is based on the combination of...
Evaluation of the switch to a dual ART regimen with lamivudine plus dolutegravir or protease inhibit...
As people live longer with HIV infection, there has been a resurgence of interest in challenging the...
A regimen with rilpivirine (RPV), abacavir (ABC) and lamivudine (3TC) is simple and may allow the sp...
To compare the efficacy and safety of an individualized treatment-simplification strategy consisting...
To compare the efficacy and safety of an individualized treatment-simplification strategy consisting...
Add to ORKG